A taxonomically representative strain collection to explore xenobiotic and secondary metabolism in bacteria. 2022

Evanthia Kontomina, and Vasiliki Garefalaki, and Konstantina C Fylaktakidou, and Dorothea Evmorfidou, and Athina Eleftheraki, and Marina Avramidou, and Karen Udoh, and Maria Panopoulou, and Tamás Felföldi, and Károly Márialigeti, and Giannoulis Fakis, and Sotiria Boukouvala
Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.

Bacteria employ secondary metabolism to combat competitors, and xenobiotic metabolism to survive their chemical environment. This project has aimed to introduce a bacterial collection enabling comprehensive comparative investigations of those functions. The collection comprises 120 strains (Proteobacteria, Actinobacteria and Firmicutes), and was compiled on the basis of the broad taxonomic range of isolates and their postulated biosynthetic and/or xenobiotic detoxification capabilities. The utility of the collection was demonstrated in two ways: first, by performing 5144 co-cultures, recording inhibition between isolates and employing bioinformatics to predict biosynthetic gene clusters in sequenced genomes of species; second, by screening for xenobiotic sensitivity of isolates against 2-benzoxazolinone and 2-aminophenol. The co-culture medium of Bacillus siamensis D9 and Lysinibacillus sphaericus DSM 28T was further analysed for possible antimicrobial compounds, using liquid chromatography-mass spectrometry (LC-MS), and guided by computational predictions and the literature. Finally, LC-MS analysis demonstrated N-acetylation of 3,4-dichloroaniline (a toxic pesticide residue of concern) by the actinobacterium Tsukamurella paurometabola DSM 20162T which is highly tolerant of the xenobiotic. Microbial collections enable "pipeline" comparative screening of strains: on the one hand, bacterial co-culture is a promising approach for antibiotic discovery; on the other hand, bioremediation is effective in combating pollution, but requires knowledge of microbial xenobiotic metabolism. The presented outcomes are anticipated to pave the way for studies that may identify bacterial strains and/or metabolites of merit in biotechnological applications.

UI MeSH Term Description Entries
D000068536 Firmicutes A phylum of predominantly GRAM-POSITIVE BACTERIA that includes the orders Bacillales and Clostridiales. Firmicutes and BACTEROIDETES are the two bacterial phyla that constitute the majority of the human gut MICROBIOTA.
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D015262 Xenobiotics Chemical substances that are foreign to the biological system. They include naturally occurring compounds, drugs, environmental agents, carcinogens, insecticides, etc. Xenobiotic
D020560 Proteobacteria A phylum of bacteria consisting of the purple bacteria and their relatives which form a branch of the eubacterial tree. This group of predominantly gram-negative bacteria is classified based on homology of equivalent nucleotide sequences of 16S ribosomal RNA or by hybridization of ribosomal RNA or DNA with 16S and 23S ribosomal RNA. Bacteria, Purple,Purple Bacteria
D064210 Secondary Metabolism A physiochemical process which occurs in a wide range of organisms which unlike BASAL METABOLISM is not required for or essential to short-term survivability but to long-term general well-being of the organism. Metabolism, Secondary,Metabolisms, Secondary,Secondary Metabolisms

Related Publications

Evanthia Kontomina, and Vasiliki Garefalaki, and Konstantina C Fylaktakidou, and Dorothea Evmorfidou, and Athina Eleftheraki, and Marina Avramidou, and Karen Udoh, and Maria Panopoulou, and Tamás Felföldi, and Károly Márialigeti, and Giannoulis Fakis, and Sotiria Boukouvala
January 1981, Methods in enzymology,
Evanthia Kontomina, and Vasiliki Garefalaki, and Konstantina C Fylaktakidou, and Dorothea Evmorfidou, and Athina Eleftheraki, and Marina Avramidou, and Karen Udoh, and Maria Panopoulou, and Tamás Felföldi, and Károly Márialigeti, and Giannoulis Fakis, and Sotiria Boukouvala
January 1979, Drug metabolism and disposition: the biological fate of chemicals,
Evanthia Kontomina, and Vasiliki Garefalaki, and Konstantina C Fylaktakidou, and Dorothea Evmorfidou, and Athina Eleftheraki, and Marina Avramidou, and Karen Udoh, and Maria Panopoulou, and Tamás Felföldi, and Károly Márialigeti, and Giannoulis Fakis, and Sotiria Boukouvala
December 1996, Biochemical pharmacology,
Evanthia Kontomina, and Vasiliki Garefalaki, and Konstantina C Fylaktakidou, and Dorothea Evmorfidou, and Athina Eleftheraki, and Marina Avramidou, and Karen Udoh, and Maria Panopoulou, and Tamás Felföldi, and Károly Márialigeti, and Giannoulis Fakis, and Sotiria Boukouvala
July 2022, Chemical research in toxicology,
Evanthia Kontomina, and Vasiliki Garefalaki, and Konstantina C Fylaktakidou, and Dorothea Evmorfidou, and Athina Eleftheraki, and Marina Avramidou, and Karen Udoh, and Maria Panopoulou, and Tamás Felföldi, and Károly Márialigeti, and Giannoulis Fakis, and Sotiria Boukouvala
January 1985, Drug metabolism and disposition: the biological fate of chemicals,
Evanthia Kontomina, and Vasiliki Garefalaki, and Konstantina C Fylaktakidou, and Dorothea Evmorfidou, and Athina Eleftheraki, and Marina Avramidou, and Karen Udoh, and Maria Panopoulou, and Tamás Felföldi, and Károly Márialigeti, and Giannoulis Fakis, and Sotiria Boukouvala
August 2007, Physiological genomics,
Evanthia Kontomina, and Vasiliki Garefalaki, and Konstantina C Fylaktakidou, and Dorothea Evmorfidou, and Athina Eleftheraki, and Marina Avramidou, and Karen Udoh, and Maria Panopoulou, and Tamás Felföldi, and Károly Márialigeti, and Giannoulis Fakis, and Sotiria Boukouvala
October 2006, The Journal of nutrition,
Evanthia Kontomina, and Vasiliki Garefalaki, and Konstantina C Fylaktakidou, and Dorothea Evmorfidou, and Athina Eleftheraki, and Marina Avramidou, and Karen Udoh, and Maria Panopoulou, and Tamás Felföldi, and Károly Márialigeti, and Giannoulis Fakis, and Sotiria Boukouvala
January 1982, Drug metabolism reviews,
Evanthia Kontomina, and Vasiliki Garefalaki, and Konstantina C Fylaktakidou, and Dorothea Evmorfidou, and Athina Eleftheraki, and Marina Avramidou, and Karen Udoh, and Maria Panopoulou, and Tamás Felföldi, and Károly Márialigeti, and Giannoulis Fakis, and Sotiria Boukouvala
June 2022, Journal of applied microbiology,
Evanthia Kontomina, and Vasiliki Garefalaki, and Konstantina C Fylaktakidou, and Dorothea Evmorfidou, and Athina Eleftheraki, and Marina Avramidou, and Karen Udoh, and Maria Panopoulou, and Tamás Felföldi, and Károly Márialigeti, and Giannoulis Fakis, and Sotiria Boukouvala
May 1989, Parasitology today (Personal ed.),
Copied contents to your clipboard!